Key facts
- It has raised $80K; the latest was Early Stage VC ($80K) in Jan 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Olivo Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Olivo Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Olivo Sciences
Developer of artificial intelligence models designed for precision neurology and drug development. The company offers multimodal data integration, domain-trained artificial intelligence models, predictive analytics, secure processing, and real-world evidence generation, enabling biopharma companies, healthcare providers, and research institutions to accelerate therapy development, improve trial efficiency, enhance patient matching, and support strategies with clinically validated insights.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2024
- Website
- olivosciences.com/
- Ownership
- Privately Held (backing)
Olivo Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Olivo Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Olivo Sciences in its N-PORT filings yet. We sweep new filings monthly.